Want to join the conversation?
Medical devices manufacturer $VAR said its ProBeam proton therapy system is the first such system to receive Saudi FDA medical devices marketing authorization. Proton therapy makes it possible to treat certain types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.